Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

About Rare Cancers Europe

Rare Cancers Europe (RCE), a 39 strong multi-stakeholder partnership, founded in 2008 and coordinated by the European Society for Medical Oncology (ESMO), brings together scientific societies, patient and research organizations, healthcare and education providers, and the industry.

About-Rare-Cancers-Europe1000x250-Our-Mission

Our Mission

Rare Cancers Europe (RCE) has been established as a partnership of cooperating stakeholders with the scope to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions, and exchange best practice.

Read more

Our Governance

The RCE initiative currently includes 39 partners grouped into 5 main stakeholder groups (scientific societies, patient and research organisations, healthcare and education providers, and the industry).

Read more

RCE Goals & Task Forces

Throughout RCE’s history, the partnership has encouraged a collaborative relationship amongst stakeholder organisations that work together to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions and exchange best practice.  Rare Cancers Europe is structured in the form of four task forces, each focusing on one of RCE’s four overarching goals.

About-Rare-Cancers-Europe1000x1000-Our-Partners

Our Partners

Rare Cancers Europe (RCE) is an initiative that brings together stakeholders, and it composed of 39 independent national and European stakeholders representing scientific societies, patient and research organisations, healthcare and education providers, and the industry.

Read more about our partners

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings